Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Hoffmann-La Roche
Hoffmann-La Roche
H. Lee Moffitt Cancer Center and Research Institute
Wake Forest University Health Sciences
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche
The University of Texas Health Science Center at San Antonio
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Loma Linda University
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Genentech, Inc.
CEL-SCI Corporation
Northwestern University
SCRI Development Innovations, LLC
Children's Oncology Group
Columbia University
Children's Oncology Group
Children's Oncology Group
Albert Einstein College of Medicine
Brown University
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Celgene
Wake Forest University Health Sciences
University of Kansas Medical Center
Hoffmann-La Roche
Children's Oncology Group
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Medical Park Gaziantep Hospital
University of Miami
SCRI Development Innovations, LLC
University of Michigan Rogel Cancer Center
Hoosier Cancer Research Network
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
NYU Langone Health
National Institutes of Health Clinical Center (CC)